Search is Powered by Google
Cancer / Oncology News

Earlier Detection Of Cancer And Better Treatment For Survivors, UK

Main Category: Cancer / Oncology
Article Date: 01 Dec 2008 - 8:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Work is well underway to catch more cancer cases earlier and improve the longer term treatment for cancer survivors, National Cancer Director Professor Mike Richards said today.

The first annual report setting out the Government's progress against the Cancer Reform Strategy, "Maintaining Momentum, Building for the Future", highlights the achievements made in the first year and identifies priorities for the year ahead.

The Cancer Reform Strategy (CRS) aims to work at both national and local levels to improve the quality of cancer services over a five-year period until 2012.

The highlights of the first year include:

- The launch of the National Awareness and Early Detection Initiative to pick up and treat cancer earlier;

- The launch of the National Cancer Survivorship Initiative which aims to ensure that the 1.6 million cancer survivors in England receive the integrated, quality services they need;

- The introduction of the HPV vaccine, which will protect women against the two strains of HPV which cause more than 70% of cervical cancer cases; and

- The successful further rollout of bowel cancer screening 2000 cancers have been detected since it began in 2006.

Health Minister Ann Keen said:

"I welcome the first annual report which details the excellent progress the NHS has made in improving cancer outcomes and services. This is evident in the reduction we have seen in mortality rates and improvement in one-year survival rates. The challenge now is to keep up this momentum and ensure that we continue to make further improvements.

"We are committed to providing cancer patients with the best possible services to taking action to prevent cancer in the first place and to detecting it at the earliest possible point. The HPV vaccination programme, extensions of the bowel and breast screening programmes and a new national awareness and early diagnosis initiative will help to make this a reality."

Professor Mike Richards said: "Cancer treatment in Britain has improved vastly in recent years and we are now beginning to see the impact on our survival rates. Recent cancer mortality figures for under 75s show that nearly 9000 lives will have been saved in 2007 compared with 1996 and we are on course to meet our target of a reduction of at least 20% in cancer death rates by 2010.

"The proposals that I set out last month in Improving access to medicines for NHS patients will also help to ensure that a greater range of more expensive drugs are made available to more cancer patients on the NHS, reducing their need to seek private drugs. Together with new proposals from NICE, this will enable patients to have faster access to more life saving cancer drugs.

"It is vital that we carry on the progress we have made in the last year and I have identified with the Cancer Reform Strategy board our key priorities for the coming year including tackling delays in diagnosing cancer and improving the quality and safety of chemotherapy services."

Harpal Kumar, Chief Executive of Cancer Research UK said: "It is good to see so much improvement in cancer treatment but we still face a great challenge. We know that cancers are often being picked up too late and we could make an enormous difference if we could speed the process up.

"We hope that the range of measures we're launching with the national cancer director through the National Awareness and Early Diagnosis Initiative will go a long way towards redressing the balance."

Ciaran Devane, chief executive of Macmillan Cancer Support said:

"We warmly welcomed the Cancer Reform Strategy when it was launched 12 months ago because it has the potential to transform the quality of services for two million people living with cancer. Implementation of the CRS locally by the NHS will ultimately determine its success for patients. We remain confident that the strategy will be fully implemented by 2012 as long as it is given higher priority by the Government and NHS locally."

Maintaining Momentum, Building For the Future - First Annual Report on Progress will be published on the DH website here.

Department of Health, UK




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...